KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Travere Therapeutics (TVTX) over the last 13 years, with Q3 2025 value amounting to 0.8.

  • Travere Therapeutics' Asset Utilization Ratio rose 10670.94% to 0.8 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.8, marking a year-over-year increase of 10670.94%. This contributed to the annual value of 0.34 for FY2024, which is 6965.47% up from last year.
  • As of Q3 2025, Travere Therapeutics' Asset Utilization Ratio stood at 0.8, which was up 10670.94% from 0.6 recorded in Q2 2025.
  • Over the past 5 years, Travere Therapeutics' Asset Utilization Ratio peaked at 0.8 during Q3 2025, and registered a low of 0.1 during Q3 2022.
  • In the last 5 years, Travere Therapeutics' Asset Utilization Ratio had a median value of 0.21 in 2024 and averaged 0.24.
  • Over the last 5 years, Travere Therapeutics' Asset Utilization Ratio had its largest YoY gain of 1007744.27% in 2022, and its largest YoY loss of 13795.88% in 2022.
  • Travere Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.0 in 2021, then skyrocketed by 10077.44% to 0.16 in 2022, then increased by 14.44% to 0.18 in 2023, then skyrocketed by 137.01% to 0.42 in 2024, then skyrocketed by 87.7% to 0.8 in 2025.
  • Its Asset Utilization Ratio was 0.8 in Q3 2025, compared to 0.6 in Q2 2025 and 0.48 in Q1 2025.